Poonam Yadav

7PUBLICATIONS
45CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell development, proliferation and deathHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2026
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.

|Aug 14, 2025
Ponatinib Averts αCD40 Antibody Mediated Toxicity by Lowering MAPK38 Expression and Shows Proimmunogenic Effects in a Murine Tumor Model.

Vidit Gaur, Anjali Barnwal, Khushboo Singh

|Feb 19, 2025
Docetaxel-conjugated bile acid-derived nanomicelles can inhibit tumour progression with reduced toxicity.

Devashish Mehta, Chhavi Dua, Ruchira Chakraborty

|Feb 13, 2025
Engineered Nanomicelles Delivering the Combination of Steroids and Antioxidants Can Mitigate Local and Systemic Inflammation, Including Sepsis.

Kajal Rana, Poonam Yadav, Ruchira Chakraborty

|May 13, 2024
Engineered nanomicelles targeting proliferation and angiogenesis inhibit tumour progression by impairing the synthesis of ceramide-1-phosphate.

Poonam Yadav, Kajal Rana, Ruchira Chakraborty

|Feb 23, 2022
Hydrogel-mediated topical delivery of steroids can effectively alleviate psoriasis via attenuating the autoimmune responses.

Kajal Rana, Trishna Pani, Somesh Kumar Jha

Pageof 2

Frequent Collaborators

6 joint publications

Avinash Bajaj

4 joint publications

Ujjaini Dasgupta

3 joint publications

Somesh Kumar Jha

3 joint publications

Devashish Mehta